$21.81
-0.15-0.68%
At Close: -
$21.81
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
LENZ Therapeutics
LENZNASDAQ
LENZ Therapeutics (NASDAQ:LENZ) Stock, Analyst Ratings, Price Targets, Forecasts
LENZ Therapeutics Inc has a consensus price target of $31.33 based on the ratings of 4 analysts. The high is $34 issued by Citigroup on April 10, 2024. The low is $28 issued by Piper Sandler on March 27, 2024. The 3 most-recent analyst ratings were released by Leerink Partners, Citigroup, and Piper Sandler on April 15, 2024, April 10, 2024, and March 27, 2024, respectively. With an average price target of $31.33 between Leerink Partners, Citigroup, and Piper Sandler, there's an implied 43.66% upside for LENZ Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Leerink Partners
Citigroup
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for LENZ Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/15/2024 | Buy Now | 46.72% | Leerink Partners | Marc Goodman | → $32 | Initiates | → Outperform | Get Alert |
| 04/15/2024 | Buy Now | — | William Blair | Tim Lugo | — | Initiates | → Outperform | Get Alert |
| 04/10/2024 | Buy Now | 55.89% | Citigroup | Yigal Nochomovitz | → $34 | Initiates | → Buy | Get Alert |
| 03/27/2024 | Buy Now | 28.38% | Piper Sandler | Joseph Catanzaro | → $28 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for LENZ Therapeutics (LENZ) stock?
The latest price target for LENZ Therapeutics (NASDAQ:LENZ) was reported by Leerink Partners on April 15, 2024. The analyst firm set a price target for $32.00 expecting LENZ to rise to within 12 months (a possible 46.72% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for LENZ Therapeutics (LENZ)?
The latest analyst rating for LENZ Therapeutics (NASDAQ:LENZ) was provided by Leerink Partners, and LENZ Therapeutics initiated their outperform rating.
When was the last upgrade for LENZ Therapeutics (LENZ)?
There is no last upgrade for LENZ Therapeutics
When was the last downgrade for LENZ Therapeutics (LENZ)?
There is no last downgrade for LENZ Therapeutics.
When is the next analyst rating going to be posted or updated for LENZ Therapeutics (LENZ)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LENZ Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LENZ Therapeutics was filed on April 15, 2024 so you should expect the next rating to be made available sometime around April 15, 2025.
Is the Analyst Rating LENZ Therapeutics (LENZ) correct?
While ratings are subjective and will change, the latest LENZ Therapeutics (LENZ) rating was a initiated with a price target of $0.00 to $32.00. The current price LENZ Therapeutics (LENZ) is trading at is $21.81, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.